collaborators

5 papers

stat.AP2026

Evidence-to-Decision (E2D): Structuring Action-Specific Evidence for Early-Phase Oncology Development

Haitao Pan

Early-phase oncology evidence is often summarized by asking whether a treatment is promising, but an encouraging signal can support several different next studies. We propose Evide…

stat.ME2026

Qualify-Then-Borrow: A Five-Step Framework for Bayesian Borrowing Beyond Outcome Agreement

Haitao Pan

PURPOSE: Dynamic Bayesian borrowing methods adapt the contribution of external information according to agreement or disagreement with current data. Qualify-Then-Borrow (QTB) makes…

stat.ME2026

Interim Monitoring as an Information-Time Alignment Problem: The WCR Framework for Time-to-Event Trials

Haitao Pan, Zhongheng Cai

Interim monitoring in time-to-event trials must balance inferential maturity with operationally meaningful timing. Event-driven designs align analyses with event accumulation but c…

stat.ME2025

A Bayesian Optimal Phase II Design for Randomized Immunotherapy Trials with Delayed Treatment Effects

Zhongheng Cai, Haitao Pan

Immunotherapy has transformed cancer treatment, yet its delayed therapeutic effects often lead to non-proportional hazards, rendering many conventional phase II designs underpowere…

stat.AP2025

A Novel Bayesian Extrapolation Design for Assessing Equivalence in Exposure-Response Curves between Pediatric and Adult Populations

Zhongheng Cai, Lian Ma, Jingjing Ye +1

Development of effective treatments in pediatric population poses unique scientific and ethical challenges in addition to the small population. In this regard, both the U.S. and E.…